Fotona Taps Robotic Surgery Veteran to Spearhead Next-Gen Laser Innovation

IRVING, TX – September 01, 2026 – In a move that signals a significant strategic pivot, medical laser and energy-based device leader Fotona has announced the creation of a Chief Product Officer (CPO) role, appointing MedTech veteran Alasdair Owen to the newly formed position. The decision to bring in an executive from the world of robotic surgery to helm product strategy at a 60-year-old laser powerhouse is more than a simple personnel update; it's a clear declaration of intent to accelerate innovation and redefine the company's place in the rapidly converging MedTech landscape.

Owen, who joins Fotona from Intuitive where he guided strategy for the renowned da Vinci robotic-assisted surgery platform, will report directly to President and CEO Jeff Duchemin. His mandate is broad and ambitious: to lead the company's global product and innovation strategy, overseeing everything from R&D and portfolio management to translating customer needs into commercialized solutions across aesthetics, dermatology, dentistry, women's health, and surgery. For a company built on the precision of light, this hire suggests a future vision that looks far beyond the beam itself.

A Strategic Shift in Product Leadership

The creation of a CPO position is a deliberate move by Fotona to centralize and elevate its innovation engine as it continues to scale globally. With a presence in over 100 countries and a customer base exceeding 60,000, the company faces the complex challenge of meeting diverse and evolving practitioner and patient needs. The new role is designed to bridge the gap between market insights and technological development, shortening the cycle from concept to clinical application.

"Alasdair has a unique ability to connect practitioner and patient insights, technology, and business strategy that will help us move faster to deliver new solutions that our customers need," said Jeff Duchemin, President and CEO of Fotona. "As we continue to expand across specialties and geographies, his leadership will strengthen our ability to deliver solutions that improve clinical outcomes, elevate patient experiences, and help practitioners grow their practices."

This move aligns with a broader trend in the MedTech industry, where the CPO role has become instrumental in navigating complex regulatory environments, integrating patient feedback, and maintaining a competitive edge through relentless innovation. In a sector where product lifecycles are shortening and technological advancements are constant, having a dedicated leader to orchestrate the entire product journey is no longer a luxury but a strategic necessity. Duchemin, who took the helm in May 2025 with a clear mandate for growth, is embedding this principle at the core of Fotona’s corporate structure.

From Robotic Surgery to Laser Precision

Alasdair Owen’s background is particularly noteworthy. His most recent experience at Intuitive involved leading European Product Portfolio Marketing for the da Vinci platform, a system that has fundamentally transformed minimally invasive surgery. Moving from the macro-level mechanics of surgical robotics to the microscopic precision of medical lasers might seem like a significant leap, but the underlying strategic disciplines are highly transferable.

At Intuitive, Owen was immersed in a world of complex system integration, intensive user training, and a constant feedback loop with top surgeons to drive product evolution. This expertise in "upstream marketing"—the process of identifying and validating market needs long before a product is developed—is precisely what Fotona aims to harness. His proven track record of partnering with key opinion leaders to shape long-term strategy will be critical as Fotona seeks to deepen its engagement with practitioners across its diverse specialties.

"Fotona has built a remarkable foundation of laser innovation over the past 60 years," Owen stated. "What attracted me to Fotona is its unique combination of scientific innovation, engineering excellence, and deep customer trust. I look forward to partnering with practitioners around the world to better understand their evolving needs and translate those insights into next-generation solutions."

His appointment suggests a future where Fotona’s devices may become more than standalone tools. The experience from the da Vinci ecosystem—with its integrated hardware, software, and data analytics—could influence the development of more connected, intelligent, and platform-based solutions at Fotona, creating a more holistic user experience for practitioners.

Reimagining a 60-Year Legacy

With over 300 patents and a history dating back to 1964, Fotona is a cornerstone of the medical laser industry. The company's strength lies in its dual-wavelength technology, particularly the combination of Er:YAG and Nd:YAG lasers, which allows for an exceptionally wide range of treatments from a single system. Its product lines, such as the Dynamis® and StarWalker® platforms, are staples in aesthetic and dermatology clinics, while the LightWalker® series has pioneered minimally invasive procedures in dentistry with patented technologies like SWEEPS® (Shock Wave-Enhanced Emission Photoacoustic Streaming).

However, the MedTech landscape is fiercely competitive. Rivals like Lumenis, Cynosure, and Candela are also aggressively innovating, often expanding into multi-energy platforms that combine laser, radiofrequency, and other modalities. In this environment, maintaining leadership requires more than just incremental improvements in laser technology. It demands a forward-looking product strategy that anticipates clinical trends and integrates user needs at the earliest stages of design.

Owen’s arrival is a clear signal that Fotona intends to lead this charge. His remit to shape the portfolio strategy across all specialties—from the high-growth aesthetics market to the highly specialized fields of surgery and gynecology—indicates a holistic approach. The goal is not just to build better lasers, but to develop comprehensive solutions that solve clinical problems, improve practice efficiency, and deliver superior patient outcomes.

The Patient and Practitioner at the Core

Ultimately, the success of this strategic shift will be measured in the clinic. The appointment of a CPO with a deep understanding of practitioner workflow and patient experience is a direct investment in the end-user. Fotona’s recent innovations, such as the "Glow Up with Fotona" concept that combines multiple laser technologies for comprehensive skin rejuvenation, already point toward a more solution-oriented approach. Owen is now tasked with scaling this philosophy across the entire organization.

His mission to "translate insights into next-generation solutions" directly addresses the industry-wide push toward patient-centric care. In aesthetics, this means developing treatments that deliver consistent, natural-looking results with minimal downtime. In dentistry, it means enabling procedures that are less painful, preserve more healthy tissue, and reduce patient anxiety. In women's health and surgery, it means providing practitioners with safer, more effective, and less invasive tools.

By tasking Owen with strengthening R&D capabilities while simultaneously deepening collaboration with practitioners, Fotona is building a framework for sustainable innovation. This customer-centric model, honed in the demanding world of robotic surgery, is poised to accelerate the development of technologies that don't just meet existing standards but create new possibilities for clinical care worldwide. The focus on empowering practitioners and improving patient outcomes is not just a talking point; it is now an executive-level mandate at the heart of the company’s global strategy.